Fukuwa Clinic

Futó vizsgálatok

• Toboroz

  A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

  NCT07794761· 3. fázis· Forrás

• Toboroz

  A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

  NCT07794774· 3. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  NCT07783425· 3. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  NCT07595549· 3. fázis· Forrás

• Toboroz

  A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

  NCT07216027· 2. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  NCT06977581· 2. fázis· Forrás

• Fut, nem toboroz

  A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  NCT05995964· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT05869903· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Elhízás3 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Asztma1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Visszavonták

  A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

  NCT06901349· 2. fázis· Forrás

• Lezárult

  A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

  NCT06109311· 3. fázis· Forrás

• Lezárult

  A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

  NCT06010004· 3. fázis· Forrás

• Lezárult

  A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

  NCT05971940· 3. fázis· Forrás

• Lezárult

  A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease

  NCT05931380· 3. fázis· Forrás

• Lezárult

  Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

  NCT05412004· 3. fázis· Forrás

• Lezárult

  A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

  NCT05362058· 3. fázis· Forrás

• Lezárult

  A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

  NCT05275400· 3. fázis· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· 3. fázis· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

  NCT04184622· 3. fázis· Forrás

• Lezárult

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· 3. fázis· Forrás